---
title: A metabolic biomarker panel of restless legs syndrome in peritoneal dialysis
  patients
date: '2022-10-18'
linkTitle: http://link.springer.com/10.1007/s11306-022-01938-z
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Restless
  legs syndrome (RLS) is a neuromotor disorder, and dialysis patients are more likely
  to develop RLS. RLS often causes sleep disorders, anxiety and depression in patients.
  It will increase the risk of death and severely affect the life of patients. At
  present, RLS has not received enough recognition and attention, and the misdiagnosis
  rate can reach more than 10%.</p> </span> <span class="a-plus-plus abstract-section
  id-a-sec2"> <h3  ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Restless legs syndrome (RLS) is a neuromotor disorder, and dialysis patients are more likely to develop RLS. RLS often causes sleep disorders, anxiety and depression in patients. It will increase the risk of death and severely affect the life of patients. At present, RLS has not received enough recognition and attention, and the misdiagnosis rate can reach more than 10%.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3  ...